Factors Affecting Drug Shortage in Aseer Hospitals
Main Article Content
Abstract
Background: drug shortage is a critical with severe negative impacts on patients’ outcome. It is a multifactorial problem in the world leading to increased cost of health, poor treatment outcomes and unnecessary patient referrals.
Purpose: this study sought to examine the various causes of drug shortage in Aseer Hospital as a foundational investigation for improvement recommendations.
To explore the factors affecting drug shortage and the magnitude of every factor’s influence in drug shortage.
Material and methods: this study applied a cross sectional descriptive research design of the quantitative methodology. A questionnaire was electronically sent to the 177 sample for completion. The data was then analyzed using the descriptive statistics of Statistical Package for Social Services (SPSS), version 26.
Results: a total of 177 questionnaires were completed. Out of the total sample, male gender dominated by 74.6% (n=132) while 25% were females. The dominant age group was (30-39) years old and most of the sampled pharmacists had bachelors in pharmacy 46.9% (n=83). In terms of experience at work, those who had worked for (5-10) years were the majority. Amongst the variables that contribute to drug shortage, this study found regulation and legislative processes (0.80=77.06%) as the major cause while imbalance between the supply and demand was the least cause (64.3%). There were other factors that contributed to drug shortage such as manufacturing problems (69.80%), drug distribution problems (69.0%) and human factor (65.57%).
Conclusion: the study findings are in agreement with most of the previous scholarly findings that cited regulation and legislative process as one of the most causes of drug shortage.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Al-Aqeel, S. A., Al-Salloum, H. F., Abanmy, N. O., & Al-Shamrani, A. A. (2010). Undispensed prescriptions due to drug unavailability at a teaching hospital in Saudi Arabia. International Journal of Health Research, 3(4), 213-216.
II. AlRuthia, Y. S., AlKofide, H., AlAjmi, R., Balkhi, B., Alghamdi, A., AlNasser, A., Alayed, A., Alshammari, M., Alsuhaibani, D., & Alathbah, A. (2017). Drug shortages in large hospitals in Riyadh: a cross-sectional study. Annals of Saudi medicine, 37(5), 375–385. https://doi.org/10.5144/0256-4947.2017.375
III. Alruthia, Y. S., Alwhaibi, M., Alotaibi, M. F., Asiri, S. A., Alghamdi, B. M., Almuaythir, G. S., ... & Alshamsan, A. (2018). Drug shortages in Saudi Arabia: Root causes and recommendations. Saudi Pharmaceutical Journal, 26(7), 947-951.
IV. Alruthia, Y. S., Alwhaibi, M., Alotaibi, M. F., Asiri, S. A., Alghamdi, B. M., Almuaythir, G. S., Alsharif, W. R., Alrasheed, H. H., Alswayeh, Y. A., Alotaibi, A. J., Almeshal, M., Aldekhail, S. N., Alhusaini, A., Alrashed, S. A., Alrumaih, A. M., Dahhas, M. A., Alghamdi, M. A., Aleheidib, M. S., Alhaidari, M. H., Alharbi, J. A., … Alshamsan, A. (2018). Drug shortages in Saudi Arabia: Root causes and recommendations. Saudi pharmaceutical journal : SPJ: the official publication of the Saudi Pharmaceutical Society, 26(7), 947–951. https://doi.org/10.1016/j.jsps.2018.05.002
V. Alsheikh, M., Seoane-Vazquez, E., Rittenhouse, B., Fox, E. R., & Fanikos, J. (2016). A Comparison of Drug Shortages in the Hospital Setting in the United States and Saudi Arabia: An Exploratory Analysis. Hospital pharmacy, 51(5), 370–375. https://doi.org/10.1310/hpj5105-370
VI. American Society of Health System Pharmacists (2020). Drug Shortages Statistics. https://www.ashp.org/Drug-Shortages/Shortage-Resources/Drug-Shortages-Statistics?loginreturnUrl=SSOCheckOnly.
VII. American Society of Health-System Pharmacists (2011). Drug Shortages Summit Report. Available at: www.ashp.org/drugshortages/summitreport.
VIII. ASHP Expert Panel on Drug Product Shortages, Fox, E. R., Birt, A., James, K. B., Kokko, H., Salverson, S., & Soflin, D. L. (2009). ASHP Guidelines on Managing Drug Product: AJHP : official journal of the American Society of Health-System Pharmacists, 66(15), 1399–1406. https://doi.org/10.2146/ajhp090026
IX. Bogaert, P., Bochenek, T., Prokop, A., & Pilc, A. (2015). A Qualitative Approach to a Better Understanding of the Problems Underlying Drug Shortages, as Viewed from Belgian, French and the European Union's Perspectives. PloS one, 10(5), e0125691. https://doi.org/10.1371/journal.pone.0125691
X. De Weerdt, E., Simoens, S., Hombroeckx, L., Casteels, M., & Huys, I. (2015). Causes of drug shortages in the legal pharmaceutical framework. Regulatory toxicology and pharmacology : RTP, 71(2), 251–258. https://doi.org/10.1016/j.yrtph.2015.01.005
XI. Dill, S., & Ahn, J. (2014). Drug shortages in developed countries--reasons, therapeutic consequences, and handling. European journal of clinical pharmacology, 70(12), 1405–1412. https://doi.org/10.1007/s00228-014-1747-1
XII. Fox, E. R., & McLaughlin, M. M. (2018). ASHP guidelines on managing drug product shortages. American Journal of Health-System Pharmacy, 75(21), 1742-1750.
XIII. Hedman L. (2016). Global Approaches to Addressing Shortages of Essential Medicines in Health Systems. WHO Drug Inf. 30, 180.
XIV. Jenzer, H., Sadeghi, L., Maag, P., Scheidegger-Balmer, F., Uhlmann, K., & Groesser, S. (2019). The European medicines shortages research network and its mission to strategically debug disrupted pharmaceutical supply chains. Pharmaceutical Supply Chains-Medicines Shortages, 1-22.
XV. Mazer‐Amirshahi, M., Pourmand, A., Singer, S., Pines, J. M., & van den Anker, J. (2014). Critical drug shortages: implications for emergency medicine. Academic Emergency Medicine, 21(6), 704-711. https://doi.org/10.1111/acem.12389
XVI. McLaughlin, M. M., Sutton, S. H., Jensen, A. O., & Esterly, J. S. (2017). Use of High-Dose Oral Valacyclovir During an Intravenous Acyclovir Shortage: A Retrospective Analysis of Tolerability and Drug Shortage Management. Infectious diseases and therapy, 6(2), 259–264.
https://doi.org/10.1007/s40121-017-0157-y
XVII. Pauwels, K., Simoens, S., Casteels, M., & Huys, I. (2015). Insights into European drug shortages: a survey of hospital pharmacists. PloS one, 10(3), e0119322. https://doi.org/10.1371/journal.pone.0119322
XVIII. Phuong, J. M., Penm, J., Chaar, B., Oldfield, L. D., & Moles, R. (2019). The impacts of medication shortages on patient outcomes: A scoping review. PloS one, 14(5), e0215837.
https://doi.org/10.1371/journal.pone.0215837
XIX. Rider, A. E., Templet, D. J., Daley, M. J., Shuman, C., & Smith, L. V. (2013). Clinical dilemmas and a review of strategies to manage drug shortages. Journal of pharmacy practice, 26(3), 183–191. https://doi.org/10.1177/0897190013482332
XX. Rinaldi, F., de Denus, S., Nguyen, A., Nattel, S., & Bussières, J. F. (2017). Drug Shortages: Patients and Health Care Providers Are All Drawing the Short Straw. The Canadian journal of cardiology, 33(2), 283–286. https://doi.org/10.1016/j.cjca.2016.08.010
XXI. Schwartzberg, E., Ainbinder, D., Vishkauzan, A., & Gamzu, R. (2017). Drug shortages in Israel: regulatory perspectives, challenges and solutions. Israel journal of health policy research, 6, 17. https://doi.org/10.1186/s13584-017-0140-9
XXII. Setayesh, S., & Mackey, T. K. (2016). Addressing the impact of economic sanctions on Iranian drug shortages in the joint comprehensive plan of action: promoting access to medicines and health diplomacy. Globalization and health, 12(1), 31. https://doi.org/10.1186/s12992-016-0168-6
XXIII. Shukar, S., Zahoor, F., Hayat, K., Saeed, A., Gillani, A. H., Omer, S., Hu, S., Babar, Z. U., Fang, Y., & Yang, C. (2021). Drug Shortage: Causes, Impact, and Mitigation Strategies. Frontiers in pharmacology, 12, 693426. https://doi.org/10.3389/fphar.2021.693426
XXIV. Shukar, S., Zahoor, F., Hayat, K., Saeed, A., Gillani, A. H., Omer, S., Hu, S., Babar, Z. U., Fang, Y., & Yang, C. (2021). Drug Shortage: Causes, Impact, and Mitigation Strategies. Frontiers in pharmacology, 12, 693426. https://doi.org/10.3389/fphar.2021.693426
XXV. Videau, M., Chemali, L., Stucki, C., Saavedra-Mitjans, M., Largana, S., Guerin, A., Bonnabry, P., Delhauteur, B., Van Hees, T., Lebel, D., & Bussières, J. F. (2019).